CAPRICOR THERAPEUTICS, INC. (CAPR) Return on equity 2017–2025
CAPRICOR THERAPEUTICS, INC. (CAPR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-34.4%FY2025 · since FY2017: 21.7% → -34.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -34.4% | -6.5 pp |
| FY2024 | -27.8% | +70.8 pp |
| FY2023 | -98.6% | +147.6 pp |
| FY2022 | -246.2% | -182.4 pp |
| FY2021 | -63.8% | -15.4 pp |
| FY2020 | -48.4% | +63.3 pp |
| FY2019 | -111.7% | +217.4 pp |
| FY2018 | -329.1% | -350.8 pp |
| FY2017 | 21.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CAPR financial trends
CAPR RevenueCAPR Net incomeCAPR Net marginCAPR Gross profitCAPR Gross marginCAPR Operating incomeCAPR Operating marginCAPR Operating cash flowCAPR Free cash flowCAPR Capital expendituresCAPR Stock buybacksCAPR Dividends paidCAPR Total assetsCAPR Total liabilitiesCAPR Shareholders’ equityCAPR overview →